BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23727129)

  • 1. Androgen treatment of postmenopausal women.
    Davis SR; Worsley R
    J Steroid Biochem Mol Biol; 2014 Jul; 142():107-14. PubMed ID: 23727129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Davis SR; Braunstein GD
    J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen therapy in women, beyond libido.
    Davis SR
    Climacteric; 2013 Aug; 16 Suppl 1():18-24. PubMed ID: 23647457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.
    Abdallah RT; Simon JA
    Int J Impot Res; 2007; 19(5):458-63. PubMed ID: 17581596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
    White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
    Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approved hormonal treatments for HSDD: an unmet medical need.
    Snabes MC; Simes SM
    J Sex Med; 2009 Jul; 6(7):1846-9. PubMed ID: 19453872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2005; 12(5):496-511; quiz 649. PubMed ID: 16145303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
    Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Role of Testosterone in The Improvement of Sexual Desire in Postmenopausal Women: An Evidence-Based Clinical Review].
    Gouveia M; Sanches R; Andrade S; Carmona S; Ferreira C
    Acta Med Port; 2018 Nov; 31(11):680-690. PubMed ID: 30521462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To be or not to be in sexual desire: the androgen dilemma.
    Nappi RE
    Climacteric; 2015 Oct; 18(5):672-4. PubMed ID: 26176767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.